摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-[2-[2-(dimethylamino)ethoxy]-5-phenylphenyl]-3-[3-[(dimethylamino)methyl]phenyl]prop-2-en-1-one

中文名称
——
中文别名
——
英文名称
(E)-1-[2-[2-(dimethylamino)ethoxy]-5-phenylphenyl]-3-[3-[(dimethylamino)methyl]phenyl]prop-2-en-1-one
英文别名
——
(E)-1-[2-[2-(dimethylamino)ethoxy]-5-phenylphenyl]-3-[3-[(dimethylamino)methyl]phenyl]prop-2-en-1-one化学式
CAS
——
化学式
C28H32N2O2
mdl
——
分子量
428.6
InChiKey
SVMQPADIHPVQPV-FYWRMAATSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    32
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    32.8
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] QUATERNARY AMINO-FUNCTIONAL CHALCONES<br/>[FR] CHALCONES COMPORTANT DES FONCTIONS AMINE QUATERNAIRE
    申请人:LICA PHARMACEUTICALS AS
    公开号:WO2005042467A1
    公开(公告)日:2005-05-12
    The present invention provides novel quaternary amino-functional chalcone derivatives and analogues exhibiting interesting antibacterial activity. The compounds have the general formula (Y1)m-Ar1(X1)-C(=O)Var2(X2)-(Y2)p (I), wherein V designates -CH2-CH2-, -CH=CH-or -C=C; Ar1 and Ar2 independently are aryl and heteroary.; m=0, 2, p=0, 1, 2, m+p>0; each Y1 and Y2 independently is -Z-N+(R1)(R2)R4 Q-(A); -NR3-Z-N+(R1)(R2)R4 Q- (B), or O-Z-N+(R1)(R2)R4 Q- (C), R1, R2, R3, R4, X1, X2 are substituents, and Q- is an anion. The present invention also relates to the compounds for sue as pharmaceutically active agents, in particular against bacterial infections (such as Gram-negative and Gram-positive bacteria, including antibiotic-sensitive or resistant strains), and in the medical treatment of bacterial infections in mammals.
    本发明提供了新型季铵功能的香豆素衍生物和类似物,具有有趣的抗菌活性。这些化合物具有通式(Y1)m-Ar1(X1)-C(=O)Var2(X2)-(Y2)p(I),其中V代表-CH2-CH2-,-CH=CH-或-C=C;Ar1和Ar2独立地是芳基和杂芳基;m=0、2,p=0、1、2,m+p>0;每个Y1和Y2独立地是-Z-N+(R1)(R2)R4Q-(A);-NR3-Z-N+(R1)(R2)R4Q-(B)或O-Z-N+(R1)(R2)R4Q-(C),其中R1、R2、R3、R4、X1、X2是取代基,Q-是阴离子。本发明还涉及这些化合物作为药物活性剂的用途,特别是对抗细菌感染(如革兰氏阴性和革兰氏阳性细菌,包括抗生素敏感或耐药菌株),以及在哺乳动物的医疗治疗中用于治疗细菌感染。
  • Aminoalkoxy-functional chalcones
    申请人:Nielsen Feldbaek Simon
    公开号:US20050227990A1
    公开(公告)日:2005-10-13
    The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.
    本发明提供了新型的烷氧基氨基查尔酮衍生物及其类似物。本发明还揭示了将该化合物或包含它们的组合物用作药物活性剂,特别是用于对抗细菌和寄生虫感染。本发明还涉及一种检测抑制作用的方法,例如对细菌、寄生虫、真菌和蠕虫的抑制作用。本发明的查尔酮带有氨基取代基,并展示出增强的生物效应和改善的代谢和物理化学性质,使得该化合物可用作药物物质,特别是作为抗寄生虫、细菌静止和杀菌剂。
  • AMINOALKOXY-FUNCTIONAL CHALCONES
    申请人:Lica Pharmaceuticals A/S
    公开号:EP1515940A2
    公开(公告)日:2005-03-23
  • QUATERNARY AMINO-FUNCTIONAL CHALCONES
    申请人:Lica Pharmaceuticals A/S
    公开号:EP1682486A1
    公开(公告)日:2006-07-26
  • Quaternary Amino-Function Chalcones
    申请人:Nielsen Simon Feldbaek
    公开号:US20080027075A1
    公开(公告)日:2008-01-31
    The present invention provides novel quaternary amino-functional chalcone derivatives and analogues exhibiting interesting antibacterial activity. The compounds have the general formula (Y 1 ) m —Ar 1 (X 1 )—C(=O)VAr 2 (X 2 )−(Y 2 ) p (I), wherein V designates —CH 2 —CH 2 —, —CH═CH— or —C≡C—; Ar 1 and Ar 2 independently are aryl and heteroaryl; m=0, 1, 2, p=0, 1, 2, m+p>0; each Y 1 and Y 2 independently is -Z—N + (R 1 )(R 2 )R 4 Q − (A); —NR 3 -Z—N + (R 1 )(R 2 )R 4 Q − (B), or —O-Z—N + (R 1 )(R 2 )R 4 Q − (C), R 1 , R 2 , R 3 , R 4 , X 1 , X 2 are substituents, and Q − is an anion. The present invention also relates to the compounds for use as pharmaceutically active agents, in particular against bacterial infections (such as Gram-negative and Gram-positive bacteria, including antibiotic-sensitive or resistant strains), and in the medical treatment of bacterial infections in mammals.
查看更多